Applied Clinical Trials
April 01, 2014
Feature Article
23
4
Examining a region's comparator reimbursement climate to better inform trial expansion decisions.
April 01, 2014
Business News
23
4
Industry news focusing on the people and organizations who work in the clinical trials profession.
April 01, 2014
News
23
4
As pair of initiatives show, the clinical trials community in Europe is working harder to get its message across to its key partner: patients.
April 01, 2014
Feature Article
23
4
The integration of pre-screening all patients for eligibility in oncology studies.
April 01, 2014
News
23
4
When examining the frequency in use of keywords related to cancer research, some important trends emerge.
April 01, 2014
View from Brussels
23
4
The advent of new drugs for tuberculosis is posing some interesting challenges for regulators in Europe.
April 01, 2014
News
23
4
Despite guidances and rules advising sponsors to include all demographic groups in clinical trials, many subgroups remain underrepresented.
April 01, 2014
CTI Insights
23
4
Half of all drugs in clinical testing are interrupted by in-licensing, co-development, joint venture and M&A arrangements – and they are taking significantly more time to develop.
April 01, 2014
A Closing Thought
23
4
The prevalence of cardiovascular toxicity associated with oncology drugs has triggered a new clinical discipline that aims to promote safer drugs and better outcomes for cancer patients.
April 01, 2014
Issue PDF
23
4
Sites: Making a Difference in Cancer Trials Accrual Trial Design: Oncology Trial Comparator Drug Reimbursement Also in this issue: Singular Approach to Combination Trials Risk Sharing and Interrupted Drug Development Cardio-Oncology: A New Clinical Discipline